We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics.read more
Anthony Pagano ā Executive Vice President and Chief Financial Officer at Genmab
Executive Bio
Mr. Pagano joined Genmab in 2007, was appointed Senior Vice President in 2011 and became the Executive Vice President and Chief Financial Officer effective March 1, 2020. Prior to joining Genmab, Mr. Pagano was Corporate Controller and Senior Director of Business Planning at NovaDel Pharma, a publicly traded specialty pharmaceutical company. He started his career at KPMG LLP, reaching the position of Manager, where he provided audit and M&A consulting services to clients ranging from start- ups to Fortune 500s in a broad range of industries.
He is a Certified Public Accountant and received a B.S. in Accounting from The College of New Jersey, as well as an M.B.A. from the Stern School of Business at New York University.
Mr. Pagano is a registered manager of Genmab with the Danish Business Authority.
Executive Team Culture Ratings from Genmab Employees
TOP
30%
Genmab's Executive Team scores in the Top 30% of similar sized companies on Comparably